| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,088 |
6,924 |
$714K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,697 |
2,348 |
$306K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,861 |
1,700 |
$184K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,570 |
1,513 |
$166K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
891 |
849 |
$92K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
380 |
355 |
$43K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,256 |
2,980 |
$40K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,158 |
1,352 |
$34K |
| 92552 |
|
1,257 |
1,188 |
$30K |
| 90677 |
|
324 |
317 |
$28K |
| D1206 |
Topical application of fluoride varnish |
846 |
840 |
$21K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
423 |
404 |
$20K |
| 90670 |
|
805 |
774 |
$19K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,591 |
1,541 |
$18K |
| 90686 |
|
742 |
716 |
$16K |
| 90697 |
|
343 |
326 |
$15K |
| 90698 |
|
588 |
573 |
$14K |
| 92551 |
|
1,189 |
1,133 |
$11K |
| 90680 |
|
344 |
337 |
$8K |
| 94760 |
|
5,225 |
4,338 |
$8K |
| 96127 |
|
834 |
786 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
264 |
238 |
$5K |
| 87807 |
|
433 |
408 |
$5K |
| 99173 |
|
1,609 |
1,541 |
$4K |
| 99177 |
|
831 |
777 |
$4K |
| 90633 |
|
157 |
149 |
$3K |
| 90744 |
|
144 |
138 |
$3K |
| 90710 |
|
90 |
86 |
$3K |
| 81002 |
|
1,158 |
1,081 |
$2K |
| 90619 |
|
30 |
26 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
14 |
13 |
$2K |
| 99381 |
|
14 |
14 |
$2K |
| 90651 |
|
68 |
61 |
$2K |
| 99383 |
|
15 |
12 |
$1K |
| 90734 |
|
54 |
49 |
$1K |
| 90656 |
|
57 |
53 |
$1K |
| 96161 |
|
422 |
404 |
$1K |
| 90696 |
|
47 |
44 |
$1K |
| 90715 |
|
31 |
24 |
$721.68 |
| 96160 |
|
136 |
133 |
$371.46 |
| 99050 |
|
67 |
57 |
$331.05 |
| 90707 |
|
14 |
14 |
$325.92 |
| 90716 |
|
13 |
13 |
$302.64 |
| 90687 |
|
12 |
12 |
$259.68 |
| 99051 |
|
87 |
74 |
$176.30 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
13 |
13 |
$120.00 |
| 3008F |
|
82 |
70 |
$51.00 |
| 36416 |
|
201 |
174 |
$21.50 |
| 99000 |
|
85 |
77 |
$12.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
16 |
14 |
$3.82 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
31 |
31 |
$0.00 |